[Bacterial sepsis in the hematologic neutropenic patient].
Todeschini
G
G
Benato
G
G
Carlini
S
S
Veneri
D
D
D000380:Agranulocytosis / Q000150:complications*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003115:Colony-Stimulating Factors / Q000627:therapeutic use; D006090:Gram-Negative Bacteria; D006094:Gram-Positive Bacteria; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000627:therapeutic use; D006402:Hematologic Diseases / Q000150:complications; D006801:Humans; D009181:Mycoses / Q000209:etiology; D009503:Neutropenia / Q000150:complications* / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology / Q000517:prevention & control
D000900:Anti-Bacterial Agents; D003115:Colony-Stimulating Factors; D006133:Growth Substances; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor
Le sepsi batteriche nel paziente neutropenico ematologico.